Thermo Fisher Scientific opened cell therapy facility at University of California, San Francisco
On Mar. 27. 2023, Thermo Fisher Scientific and the University of California, San Francisco, announced they will accelerate…
Oragenics engages KBI Biopharma to support development of intranasal COVID-19 vaccine candidate NT-CoV2-1
On Mar. 10, 2022, Oragenics announced that it had entered into an agreement with KBI Biopharma for the…
Thermo Fisher and University of California, San Francisco announced cell therapy cGMP manufacturing and collaboration center
On May 19, 2021, Thermo Fisher Scientific and the University of California, San Francisco (UCSF) announced they have…
CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling review
On Apr. 19, 2021, CytoDyn announced it had submitted the manufacturing section (CMC) of the application for an…
INOVIO expanded global manufacturing consortium for COVID-19 vaccine candidate with Kaneka Eurogentec
On Dec. 3, 2020, Inovio Pharmaceuticals announced the execution of an agreement with Kaneka Eurogentec an affiliate of…
Rentschler Biopharma contributed to manufacturing of COVID-19 mRNA vaccine
On Oct. 7, 2020, Rentschler Biopharma announced an agreement to serve as CDMO partner for BioNTech. As an…
Bio-Techne announced opening of GMP manufacturing facility in Twin Cities
On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…
BioNTech acquired GMP manufacturing site to expand COVID-19 vaccine production
On Sept. 17, 2020, BioNTech announced an agreement with Novartis to acquire their GMP certified manufacturing facility in…
Airway Therapeutics and Celonic Group collaborated to produce AT-100 as promising new candidate for Coronavirus
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
Vaxart announced selection of its oral COVID-19 vaccine lead candidate
On May 20, 2020, Vaxart announced it had selected its lead COVID-19 vaccine candidate and had contracted with…
NantKwest announced FDA authorization of IND application for mesenchymal stem cell product for treatment of severe COVID-19 patients
On May 18, 2020, NantKwest announced it had received authorization from the FDA for an Investigational New Drug…
Biotechnology | COVID-19 | Life Science News | Nanotechnology | Pharmaceutical | Therapeutics | Vaccine
Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
HALIX entered collaboration with University of Oxford for GMP manufacturing of a COVID-19 vaccine
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
VGXI established pilot mRNA manufacturing capabilities
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
Fosun Pharma and BioNTech formed COVID-19 vaccine strategic alliance in China
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
Clover and GSK announced research collaboration to evaluate Coronavirus vaccine candidate with pandemic adjuvant system
On Feb. 24, 2020, Clover Biopharmaceuticals announced a research collaboration with GSK for its protein-based coronavirus vaccine candidate…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Therapeutics | Vaccine | Women's Health
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
Just – Evotec Biologics initiated construction of first JPOD Facility in North America
On Jan. 14, 2020, Evotec announced that the wholly-owned Seattle based company Just – Evotec Biologics had initiated…
HHS awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities
On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur…
Siteman Cancer Center established a Good Manufacturing Practice (GMP) facility
In 2004, the Siteman Cancer Center established a Good Manufacturing Practice (GMP) facility, the first built in partnership…
The FDA announced the current good manufacturing practice (cGMP) initiative
On Aug. 21, 2002, the FDA announced an effort to enhance and update the regulation of manufacturing processes…
FDA announced initiative to modernize the regulation of pharmaceutical manufacturing
On Aug. 21, 2002, the FDA announced an initiative to modernize the regulation of pharmaceutical manufacturing and product…
University of Iowa began pharmaceutical production
In Jul. 1974, In the Division of Pharmaceutical Service at the University of Iowa began producing cGMP compliant…